SG Americas Securities
ATOS icon

SG Americas Securities’s Atossa Therapeutics ATOS Stock Holding History

SG Americas Securities’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,483
Closed -$25K – 2933
2025
Q1 		$25K Sell
2,483
-4,441
-64% -$53.9K ﹤0.01% 3356
2024
Q4 		$98K Buy
6,924
+4,134
+148% +$80.7K ﹤0.01% 2750
2024
Q3 		$64K Buy
2,790
+2,003
+255% +$40.4K ﹤0.01% 3190
2024
Q2 		$14K Buy
+787
New +$17.4K ﹤0.01% 2774
2022
Q2 		– Sell
-728
Closed -$14K – 3411
2022
Q1 		$14K Sell
728
-1,690
-70% -$34.3K ﹤0.01% 2895
2021
Q4 		$58K Sell
2,418
-3,059
-56% -$112K ﹤0.01% 3172
2021
Q3 		$268K Buy
+5,477
New +$319K ﹤0.01% 3023

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return